Tildacerfont |
| Catalog No.GC65893 |
Tildacerfont는 강력하고 경구 활성 코르티코트로핀 방출 인자 유형 1(CRF1) 수용체 길항제입니다. 821d96072c2d58d8970e76f526b0f6b8Tildacerfont는 부신피질자극호르몬(ACTH)과 부신 안드로겐 수치를 효과적으로 감소시킵니다. 821d96072c2d58d8970e76f526b0f6b8Tildacerfont는 유리한 안전 프로필을 가지고 있습니다. 821d96072c2d58d8970e76f526b0f6b8Tildacerfont는 선천성 부신 증식증 연구에 사용할 수 있습니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1014983-00-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *